IMAC Holdings, Inc. has launched Ignite Proteomics LLC, a new subsidiary focused on enhancing cancer treatment personalization through protein-level analysis. This initiative aims to improve the ...
Ignite Proteomics LLC announced the publication of a pivotal study in the British Journal of Cancer, which emphasizes the importance of measuring activated proteins in the AKT–mTOR signaling pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback